We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
About us / EXECUTIVE COMMITTEE
Neuraxpharm executive team

Neuraxpharm's Executive Committee

CEO

Dr Jörg-Thomas Dierks

Dr Jörg-Thomas Dierks

CEO

Dr Jörg-Thomas Dierks has 30 years of healthcare experience, having held several senior executive positions in the pharmaceutical industry. Most recently, he has been the CEO of Meda, a Sweden-based speciality pharma company, a position he has held since 2013. Before becoming CEO, Jörg was the Chief Operating Officer (COO) for Meda from 2005 to 2013 and also assumed the role of Chief Scientific Officer (CSO) for a period of time. He was instrumental in growing the business over many years and leading its sale to Mylan in 2016 for $10bn. Before joining Meda, Jörg was the COO of Viatris, a Germany-based pharmaceutical company.

Born in Bad Kreuznach, Germany, Dr Dierks graduated from Johannes-Gutenberg-Universität zu Mainz with a degree in human medicine, which included one year working in a hospital in Koblenz in 1986, earning him the title of medical doctor. One year later, Jörg was awarded the title of Doctor of Medicine. Dr Dierks also studied Business Administration for Scientists at the Fernuniversität Gesamthochschule in Hagen.

More

EXPERTS

Lluís Pérez Neuraxpharm

Lluís Pérez

CHIEF FINANCIAL OFFICER

Lluís Pérez’s professional background and expertise are focused in the fields of Corporate Finance Control and Finance, having extensive international experience in large, multinational companies.

For more than eight years, Lluís developed his professional career as Group CFO in various Business Units of the second largest steel producer in Europe, Celsa Group (with bases in the UK, Scandinavia and Poland) and as Group CFO of Goldcar (private equity owned), his most recent position.

He is an expert in the integration of subsidiaries, in coordinating multi-site Finance departments, refinancing, analysing the feasibility of new investments and leading M&A processes.

Lluís holds a Bachelor’s degree (BSc) in Business Economics from the Universitat Autònoma de Barcelona and an E-MBA.

More
Dr Christoph Koch

Aida Fernandez

CHIEF HUMAN RESOURCES OFFICER

With more than 15 years of experience in the pharmaceutical industry, Aida Fernandez is a global HR professional with extensive business knowledge.

Aida has ample experience in local and global roles, which includes working in international headquarters. She has a proven track record in implementing organisational changes, applying change management methodology and ensuring business success in local, global and corporate environments in different countries and cultures.

Aida combines her human resources background with a Bachelor’s degree in Psychology and an Executive MBA from ESADE.

She developed her professional career in Novartis and in one of the Big 4 Accounting Firms.

More
BURGHARD BURCZYK

BURGHARD BURCZYK

CHIEF TECHNOLOGY OFFICER

Burghard Burczyk has more than 20 years of leadership experience in international companies and is an expert in successfully implementing strategic planning in the fields of purchasing, production, technology and supply chain.

He has a proven track record in product transfer and in procurement management within several pharmaceutical companies, including Haupt Pharma, Aristo and Ethypharm. At the same time, Burghard Burczyk has extensive experience as a strategic consultant in the supply chain and tender business.

Burghard has a degree in Mechanical Engineering from the University of Magdeburg, Germany.

More
TEAM_METAS_MEMBER05_FOTO_ALT

DR CHRISTOPH KOCH

CHIEF BUSINESS DEVELOPMENT OFFICER
Dr Christoph Koch is Chief Business Development Officer at Neuraxpharm. His role involves looking after the group’s product portfolio, which includes both in- and out-licensing activities, as well as growing Neuraxpharm’s footprint through M&A activities.

Christoph joined Neuraxpharm in August 2017, coming from DSM Sinochem Pharmaceuticals, where he had been developing the B2B licensing of Drug Products.

Originally a scientist with a PhD in Organic Chemistry from the University of Cologne, Christoph has more than 15 years’ industry experience having previously worked in leading BD roles for Heumann Pharma, the German subsidiary of Torrent Pharmaceuticals, and Helm in Hamburg.

Christoph has lived in Belgium, Germany and the Netherlands and is now based in Barcelona.
More
TEAM_METAS_FRANCISCO_FOTO_ALT

Francisco Jurado

CHIEF SCIENTIFIC OFFICER

Francisco Jurado has more than 28 years of experience in the pharmaceutical industry, in product selection and the definition of strategic R&D projects, offering extensive knowledge in generic drug development, new chemical entities (NCE), line extensions and OTC products.

He has been leading multidisciplinary teams of a high functional capacity in the areas of Pharmaceutical Development (formulation and analytical), Clinical Development, Intellectual Property, Regulatory Affairs and Project Management, in addition to integrating all internal capabilities including everything from APIs to final dosage forms.

Francisco has developed his professional career as the Head of Pharmaceutical Development at Lacer Laboratories, R&D Pharma Director at Chemo Group, and his last position as the Corporate Product Development Director at Ferrer Group.

He holds a Bachelor’s Degree in Pharmacy from the University of Barcelona and he is a Pharmaceutical Industry Specialist.

More
TEAM_METAS_DAN_FOTO_ALT

Dan Furrer

HEAD OF CORPORATE MARKETING

Dan Furrer has over 20 years of experience in building and running marketing operations in the pharmaceutical industry, having participated in several company turnarounds, product and company acquisitions, company integrations and strategic changes.

He joins Neuraxpharm from Mylan, where he was Country Manager in the Czech Republic, and Meda Pharma, prior to the acquisition by Mylan, where he was Country Manager for Germany and Switzerland. He was also Country Manager at Spirig Pharma Switzerland and held several positions in marketing, including Head of International Marketing, Marketing & Regional Sales Manager and Product Manager in CNS at different companies.

Dan Furrer holds a Masters in Industrial Management and a Masters in Pharmacy from the Swiss Federal Institute of Technology in Zurich.

More

COUNTRY MANAGERS

GERMANY

TEAM_METAS_MEMBER06_FOTO_ALT

DR OLAF KRAMPE

COUNTRY MANAGER
With a proven track record of over 20 years in the pharmaceutical industry, Olaf has always been involved in the commercial and marketing fields, mainly in the CNS area. He has a Chemistry degree and a PhD from Universität Paderborn.

He started his career in 1998 as part of the sales force at Desitin, a CNS related-company. He then worked for more than 10 years in Temmler/Aenova, where until 2014 he occupied several positions, from Product Manager to Senior Product Manager, he was then promoted to Head of Marketing & Sales and finally appointed as Director of own products, including CNS products and CMO Business.
More

SPAIN

TEAM_METAS_MEMBER08_FOTO_ALT

JAVIER MERCADÉ

COUNTRY MANAGER
Javier Mercadé is the General Manager of Neuraxpharm Spain and Laboratorios Lesvi, our commercial subsidiary and our Finished Dosage Form production unit in Spain. He has more than 25 years of experience in the Pharmaceutical industry in various senior roles.

Javier joined our company in 2006, leading the development of Neuraxpharm Spain from the beginning. Previously, he has also had different commercial responsibilities in Procter & Gamble, Vita, Roche and Prodesfarma.

Javier holds a degree in Pharmacy from the University of Barcelona, and on the business side, he has an MBA from ESADE and a PDG from IESE business school.


More

ITALY

TEAM_METAS_MEMBER09_FOTO_ALT

MARCO MARCHETTI

COUNTRY MANAGER
Marco Marchetti is currently the Managing Director of Neuraxpharm Italy. He co-founded the Italian subsidiary of the Group, previously known as FB Health, 8 years ago with the purpose of becoming a reference company for CNS Specialists in the Italian market.

Marco has significant experience in managing start-ups and fast-growing companies. He co-founded FB Vision, an important ophthalmic pharmaceutical group, and served as Board Member in several research-driven companies, such as FB Dermatology.

He has a Master’s degree in Biotechnology from the University of Bologna with a specialisation in bioinformatics. He also has an MBA from LUISS Guido Carli University in Rome.
More

FRANCE

TEAM_METAS_MEMBER10_FOTO_ALT

DR PIERRE-HERVÉ BRUN

COUNTRY MANAGER
Over 30 years of experience in the pharmaceutical industry, Dr Pierre-Hervé Brun’s professional background and expertise are focused in the fields of Business Development, Market Access & Commercial Operations management.

He started his career in R&D at Rhone-Poulenc Rorer, and has held various management roles at Negma-Lerads and Therabel. Later on, he joined Aptalis Pharma (formerly Axcan Pharma) as Senior EU Business Development Director, a company where he later fulfilled the functions of Deputy General Manager and Commercial Operation Director. In addition, as a Consultant he assisted Pharma and Biotech companies to strengthen their commercial, Business Development and Market Access strategies.

Pierre-Hervé holds a Doctorate in Pharmacy & a Biology Degree from the University of Paris V and VI, and a Master in Applied and Basic Toxicology from the University of Paris VII.
More

CZECH REPUBLIC AND SLOVAKIA

DR LUKÁŠ JIRKA

COUNTRY MANAGER
After graduating as a Doctor of Medicine (M.D.) from Charles University in Prague in 1999, Dr Lukáš Jirka joined MSD Czech Republic where he spent five years in various management positions within Sales and Marketing.

In 2004, Lukáš was appointed as the General Manager of SVUS Pharma, a Czech contract packaging organisation for the pharmaceutical industry with the aim of building their portfolio of both generic and OTC products, and selling these products within the whole CEE region. He changed SVUS’ focus from contract packaging to the marketing and distribution of their own pharmaceutical products and subsequently became a company shareholder.

In February 2019 Neuraxpharm acquired SVUS’s commercial division Farmax and this was rebranded as Neuraxpharm Bohemia.
More

MANUFACTURING PLANTS

LESVI

JAVIER MERCADÉ

GENERAL MANAGER
Javier Mercadé is the General Manager of Neuraxpharm Spain and Laboratorios Lesvi, our commercial subsidiary and our Finished Dosage Form production unit in Spain. He has more than 25 years of experience in the Pharmaceutical industry in various senior roles.

Javier joined our company in 2006, leading the development of Neuraxpharm Spain from the beginning. Previously, he has also had different commercial responsibilities in Procter & Gamble, Vita, Roche and Prodesfarma.

Javier holds a degree in Pharmacy from the University of Barcelona, and on the business side, he has an MBA from ESADE and a PDG from IESE business school.

More

INKE

TEAM_METAS_MEMBER12_FOTO_ALT

MIQUEL BACHS

GENERAL MANAGER
Miquel has a strong professional background focused on the Commercial and Business Development fields, with considerable experience in B2B (FDF and API business) and also B2C (leading pharmaceuticals sales forces). He has extensive knowledge in the definition and execution of global strategic commercial policies, as well as in the development and enhancement of business and marketing plans and planning strategies.

Miquel developed his professional career as Sales Manager and BD Manager at Procter & Gamble and Laboratorios Vita (former parent company of Laboratorios Lesvi) and was also the Commercial & Supply Chain Director of Tamarang Pharmaceuticals (sister company of Farmhispania), his most recent position.

Miquel holds a Bachelor’s degree (BSc) in Veterinary Medicine from the Universitat Autònoma de Barcelona and a Master in Commercial Management and Marketing from EAE Business School.

More
Cookies de terceiros